sk&f-38393 has been researched along with Alloxan Diabetes in 5 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both the anorectic response on the first day of dosing and the tolerant response on the subsequent days were attenuated." | 5.33 | Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists. ( Kuo, DY, 2006) |
| " Both the anorectic response on the first day of dosing and the tolerant response on the subsequent days were attenuated." | 1.33 | Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists. ( Kuo, DY, 2006) |
| "Pretreatment with quinpirole, a selective dopamine D2 agonist, (100 nmol, i." | 1.29 | Involvement of dopamine D2 receptor-mediated functions in the modulation of morphine-induced antinociception in diabetic mouse. ( Kamei, J; Saitoh, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marwaha, A | 1 |
| Banday, AA | 1 |
| Lokhandwala, MF | 1 |
| Kuo, DY | 1 |
| Wang, YX | 1 |
| Brooks, DP | 1 |
| Kamei, J | 1 |
| Saitoh, A | 1 |
| Barthelmebs, M | 1 |
| Vailly, B | 1 |
| Grima, M | 1 |
| Velly, J | 1 |
| Stephan, D | 1 |
| Froehly, S | 1 |
| Imbs, JL | 1 |
5 other studies available for sk&f-38393 and Alloxan Diabetes
| Article | Year |
|---|---|
Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Diabetes Mellitus, Experimental | 2004 |
Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Diabetes | 2006 |
Effect of dietary protein on the renal response to fenoldopam in diabetic rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Diabetes Mellitus | 1993 |
Involvement of dopamine D2 receptor-mediated functions in the modulation of morphine-induced antinociception in diabetic mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Animals; Behavior, A | 1996 |
Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Carbidopa; Diabet | 1991 |